Holger Monenschein

1.7k total citations
32 papers, 1.1k citations indexed

About

Holger Monenschein is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Holger Monenschein has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Holger Monenschein's work include Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (8 papers) and Receptor Mechanisms and Signaling (5 papers). Holger Monenschein is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Synthetic Organic Chemistry Methods (8 papers) and Receptor Mechanisms and Signaling (5 papers). Holger Monenschein collaborates with scholars based in Germany, United States and United Kingdom. Holger Monenschein's co-authors include Andreas Kirschning, Rüdiger Wittenberg, Carsten Schmeck, K. C. Nicolaou, Konstantina C. Fylaktakidou, Helen J. Mitchell, Yiwei Li, Kazuyuki Sugita, Kai‐Uwe Schöning and A. J. Roecker and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Biological Psychiatry.

In The Last Decade

Holger Monenschein

31 papers receiving 1.1k citations

Peers

Holger Monenschein
Izzat T. Raheem United States
Ruijie K. Zhang United States
Karel M. J. Brands United States
Braddock A. Sandoval United States
Marvin M. Hansen United States
Wen‐Ju Bai United States
Holger Monenschein
Citations per year, relative to Holger Monenschein Holger Monenschein (= 1×) peers István Greiner

Countries citing papers authored by Holger Monenschein

Since Specialization
Citations

This map shows the geographic impact of Holger Monenschein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Monenschein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Monenschein more than expected).

Fields of papers citing papers by Holger Monenschein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Monenschein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Monenschein. The network helps show where Holger Monenschein may publish in the future.

Co-authorship network of co-authors of Holger Monenschein

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Monenschein. A scholar is included among the top collaborators of Holger Monenschein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Monenschein. Holger Monenschein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffer, Hans H., Holger Monenschein, Josephine M. Atienza, et al.. (2021). Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia. Journal of Medicinal Chemistry. 64(15). 11527–11542. 24 indexed citations
2.
Brice, Nicola, Lee A. Dawson, David Margolin, et al.. (2021). Identification of CVN058, a Novel Brain Penetrant, Selective 5-HT3 Receptor Antagonist That Shows Efficacy in Pre-Clinical Cognition Models. Biological Psychiatry. 89(9). S26–S26. 2 indexed citations
3.
Cilia, Jackie, et al.. (2018). S39. GPR139 AN OPHAN GPCR AFFECTING NEGATIVE DOMAINS OF SCHIZOPHRENIA. Schizophrenia Bulletin. 44(suppl_1). S339–S339. 7 indexed citations
4.
Pennington, Lewis D., Douglas A. Whittington, Michael D. Bartberger, et al.. (2013). Hydroxyethylamine-based inhibitors of BACE1: P1–P3 macrocyclization can improve potency, selectivity, and cell activity. Bioorganic & Medicinal Chemistry Letters. 23(15). 4459–4464. 16 indexed citations
5.
Monenschein, Holger, Daniel B. Horne, Michael D. Bartberger, et al.. (2012). Structure guided P1′ modifications of HEA derived β-secretase inhibitors for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 22(11). 3607–3611. 9 indexed citations
6.
Zeng, Qingping, Matthew P. Bourbeau, Holger Monenschein, et al.. (2010). 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 20(5). 1652–1656. 15 indexed citations
7.
Horne, Daniel B., Michael D. Bartberger, Matthew R. Kaller, et al.. (2009). Synthesis and conformational analysis of α,α-difluoroalkyl heteroaryl ethers. Tetrahedron Letters. 50(39). 5452–5455. 17 indexed citations
8.
Nicolaou, K. C., Yiwei Li, Kazuyuki Sugita, et al.. (2004). Total Synthesis of Apoptolidin: Completion of the Synthesis and Analogue Synthesis and Evaluation.. ChemInform. 35(14). 1 indexed citations
9.
Monenschein, Holger, et al.. (2004). Acylation of Alkyl Halides and Amino Aldehydes with a Phosphane Oxide‐Based d1‐Synthon. European Journal of Organic Chemistry. 2004(5). 1149–1160. 6 indexed citations
10.
Nicolaou, K. C., et al.. (2003). Studies Towards the Synthesis of Azadirachtin: Enantioselective Entry into the Azadirachtin Framework through Cascade Reactions. Angewandte Chemie International Edition. 42(31). 3637–3642. 40 indexed citations
11.
Monenschein, Holger, et al.. (2002). ChemInform Abstract: Lithiated Dimethoxymethyl Diphenyl Phosphine Oxide, a Verstatile Formiate Carbanion Equivalent.. ChemInform. 33(28). 1 indexed citations
12.
Monenschein, Holger, et al.. (2002). Lithiated Dimethoxymethyl Diphenyl Phosphine Oxide, A Versatile Formiate Carbanion Equivalent. Synlett. 2002(3). 525–527. 9 indexed citations
13.
Kirschning, Andreas, Holger Monenschein, & Rüdiger Wittenberg. (2001). Functionalized Polymers-Emerging Versatile Tools for Solution-Phase Chemistry and Automated Parallel Synthesis. Angewandte Chemie International Edition. 40(4). 650–679. 333 indexed citations
14.
Kirschning, Andreas, Holger Monenschein, & Rüdiger Wittenberg. (2000). The “Resin-Capture-Release” Hybrid Technique: A Merger between Solid- and Solution-Phase Synthesis. Chemistry - A European Journal. 6(24). 4445–4450. 35 indexed citations
15.
Kirschning, Andreas, Holger Monenschein, & Rüdiger Wittenberg. (2000). The “Resin-Capture–Release” Hybrid Technique: A Merger between Solid- and Solution-Phase Synthesis. Chemistry - A European Journal. 6(24). 4445–4450.
16.
Kirschning, Andreas, et al.. (1999). Preparation of Novel Haloazide Equivalents by Iodine(III)-Promoted Oxidation of Halide Anions. The Journal of Organic Chemistry. 64(17). 6522–6526. 62 indexed citations
17.
Kirschning, Andreas, Holger Monenschein, & Carsten Schmeck. (1999). Stabiles festphasengebundenes Iodazid. Angewandte Chemie. 111(17). 2720–2722. 24 indexed citations
18.
Monenschein, Holger, et al.. (1999). Asymmetric Nucleophilic Acylation of Aldehydes via 1,1-Heterodisubstituted Alkenes. Chemistry - A European Journal. 5(8). 2270–2280. 25 indexed citations
19.
Kirschning, Andreas, Holger Monenschein, & Carsten Schmeck. (1999). Stable Polymer-Bound Iodine Azide. Angewandte Chemie International Edition. 38(17). 2594–2596. 65 indexed citations
20.
Kaiser, Volker, et al.. (1997). Product Analysis in the Iodine(III)‐Promoted Oxidation of Carbohydrate‐Derived Cyclic Enol Ethers: A Mechanistic Study. Liebigs Annalen. 1997(10). 2125–2132. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026